4//SEC Filing
Adamas Pharmaceuticals Inc 4
Accession 0001104659-14-065503
CIK 0001328143operating
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 7:30 PM ET
Size
6.8 KB
Accession
0001104659-14-065503
Insider Transaction Report
Form 4
BOOTH RICHARD H
Director
Transactions
- Exercise of In-Money
Common Stock
2014-09-05$4.50/sh+17,778$80,001→ 53,778 total - Exercise of In-Money
Common Stock Warrant
2014-09-05−17,778→ 0 totalExercise: $4.50Exp: 2014-09-25→ Common stock (17,778 underlying)
Footnotes (1)
- [F1]The Common Stock Warrant may be exercised through cash payment of the purchase price or through net exercise before the expiration date.
Documents
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001328143
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 7:30 PM ET
- Size
- 6.8 KB